AKRON, OHIO (Aug. 27, 2:45 p.m. EDT) — Some environmentalists have PVC in the firing line, but PVC continues to play a vital role in life-saving medical applications. Senior officials from Baxter Healthcare Corp. and custom injection molder Nypro Inc. will shed some light on resin development efforts, as well as on prospects and challenges in the medical products market, when they address Plastics News' Executive Forum 2000 in Lake Buena Vista, Fla., this fall.
Terry Kochersperger, director of Baxter's IV Systems Technical Center in Round Lake, Ill., and Samuel Landol, vice president of Latin America, corporate quality and administration for Clinton, Mass.-based Nypro, both will speak to forum attendees on the morning of Oct. 16 at the Grand Floridian Resort & Spa in Lake Buena Vista.
A talk assessing PVC resin prospects immediately precedes the medical end-market session, which will be moderated by Len Czuba, director of the medical section for Herbst LaZar Bell Inc., a Chicago-based product design and development house. Czuba also twice has served as chairman of the Medical Plastics Division of the Society of Plastics Engineers.
Kochersperger is a chemical engineer who has been at Baxter since 1976. Plastics-related activity at the Technical Center includes resin selection, material cost-reduction projects, resin supplier process change approvals, part design, molding, assembly and material approvals. The center also is responsible for injection molding, and design and approval of injection molds.
Landol worked in sales and management for Digital Inc. in the Carribbean for eight years before joining Nypro in 1991 as president and general manager of Nypro Puerto Rico Inc. A past chairman of the Puerto Rico Manufacturers Association, he currently is overseeing Nypro's expansion in the Dominican Republic and Mexico.
For more details, call Nancy Parks in Akron at 330-865-6134 or e-mail her at [email protected].